Click it and Unblock the Notifications
Just In
Don't Miss
-
Ranam Aram Thavarel Full Movie Leaked Online In HD For Free Download Hours After It Hit The OTT Platform -
Ford Territory SUV Name Trademarked – Likely To Be Positioned Below The Everest SUV -
Roman Reigns transitioning to Hollywood after WWE WrestleMania 40 loss -
IRFC, RVNL, IRCTC, Railtel: Railway Stocks In Focus As Election Polls Begin; Mega Rs 10-12 Lakh Crore Plan -
OnePlus Ace 3 Pro Leak Hints at New Design; Expected Launch, Specifications We Know So Far -
Summer Fashion: Your Bollywood Style White Outfits Guide To Keep It Cool And Chic -
Journey From Delhi To Ooty: Top Transport Options And Attractions -
IIIT-Bangalore Introduces PG Diploma In Digital Product Design And Management
Pfizer launches pneumonia-prevention vaccine
Mumbai, Jul 9: A new variant of pneumonia-prevention vaccine came in Indian market on Thursday, Jul 8 as global pharma major Pfizer launched Prevanar-13.
Kewal Handa, Pfizer Managing Director told that every year India recorded over 3.71 lakh infant deaths due to pneumonia.
He also added that the vaccine had a very large opportunity as every year around 25 million births occurred in India.
Pfizer's recently acquired subsidiary, Wyeth, will be handling the product in India. The company now sells the new version of Prevanar in 30 countries.
Handa said that a single course costs over Rs.15,000 spread across four doses and the company was trying to get the product included in the national immunization programme which will give a boost to sales.
When asked about the revenue generation from the new line, he Handa said,"awareness of the medical fraternity and market expansion are the key."
OneIndia News
